Why the study?
Does streptokinase improve survival in a pregnant patient with massive pulmonary embolism in shock?
Does streptokinase improve survival in a pregnant patient with massive pulmonary embolism in shock?
Streptokinase therapy successfully treated massive pulmonary embolism with shock in a pregnant patient, though it was complicated by fetal death.
Answers are grounded in this paper and cite their sources.
May support thrombolysis for maternal salvage in peripartum PE shock; hypothesis-generating and should not change practice.
A 24-year-old multipara 34 weeks pregnant presented in shock due to massive pulmonary embolism. Recovery followed thrombolytic therapy, although fetal death occurred early. There were no serious maternal side effects, although hypofibrinogenaemia occurred. Thrombolytic therapy is considered to offer advantages over heparin in this situation.
No takes yet. Share an insight, caveat, or question.
McTaggart et al. (1977) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: